Evvy

Evvy is a commercial-stage digital health company pioneering a vertically integrated platform for vaginal health. Its core offering is a direct-to-consumer at-home vaginal microbiome test, which leverages advanced metagenomic next-generation sequencing (mNGS) to identify 700+ bacteria and fungi. Results are reviewed by affiliated clinicians who can prescribe targeted treatments, creating a closed-loop diagnostic-to-therapeutic model. The company supplements this with a line of proactive wellness products (e.g., probiotics, boric acid) and a membership for tracking microbiome changes over time.

CLIA-certified, at-home vaginal microbiome test using metagenomic next-generation sequencing (mNGS) to identify 700+ bacteria and fungi, integrated with a telehealth platform for clinician-reviewed results and prescription treatment.

Evvy competes in the emerging vaginal microbiome testing space with companies like Juno Bio, as well as broader women's health telehealth platforms (e.g., Nurx, Wisp) and traditional diagnostic labs offering vaginal pathogen panels. Its primary differentiation is the use of comprehensive mNGS technology and its vertically integrated care model from testing to treatment.